Literature DB >> 34250390

Lung Cancer in Li-Fraumeni Syndrome.

Kathleen Kerrigan1, Jessica Chan2, Jennie Vagher3, Wendy Kohlmann3, Anne Naumer3, Jo Anson3, Sara Low3, Joshua Schiffman4, Luke Maese4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34250390      PMCID： PMC8232233          DOI： 10.1200/PO.20.00468

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  25 in total

1.  Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.

Authors:  Mandy L Ballinger; Ana Best; Phuong L Mai; Payal P Khincha; Jennifer T Loud; June A Peters; Maria Isabel Achatz; Rubens Chojniak; Alexandre Balieiro da Costa; Karina Miranda Santiago; Judy Garber; Allison F O'Neill; Rosalind A Eeles; D Gareth Evans; Eveline Bleiker; Gabe S Sonke; Marielle Ruijs; Claudette Loo; Joshua Schiffman; Anne Naumer; Wendy Kohlmann; Louise C Strong; Jasmina Bojadzieva; David Malkin; Surya P Rednam; Elena M Stoffel; Erika Koeppe; Jeffrey N Weitzel; Thomas P Slavin; Bita Nehoray; Mark Robson; Michael Walsh; Lorenzo Manelli; Anita Villani; David M Thomas; Sharon A Savage
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

2.  Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial.

Authors:  Olivier Caron; Thierry Frebourg; Patrick R Benusiglio; Stéphanie Foulon; Laurence Brugières
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

3.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

4.  EGFR-mutated lung cancer in Li-Fraumeni syndrome.

Authors:  Vasiliki Michalarea; Matthew Calcasola; Paul Cane; Khalid Tobal; Louise Izatt; James Spicer
Journal:  Lung Cancer       Date:  2014-06-30       Impact factor: 5.705

Review 5.  EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.

Authors:  Charles Ricordel; Marie Labalette-Tiercin; Alexandra Lespagnol; Mallorie Kerjouan; Catherine Dugast; Jean Mosser; Benoit Desrues; Hervé Léna
Journal:  Lung Cancer       Date:  2014-11-20       Impact factor: 5.705

6.  Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.

Authors:  Lisa A Cannon-Albright; Shamus R Carr; Wallace Akerley
Journal:  J Thorac Oncol       Date:  2019-05-07       Impact factor: 15.609

7.  Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.

Authors:  Anh N Le; Joanna Harton; Heena Desai; Jacquelyn Powers; Kristin Zelley; Angela R Bradbury; Katherine L Nathanson; Payal D Shah; Abigail Doucette; Gary M Freedman; Peter Gabriel; Susan M Domchek; Suzanne P MacFarland; Kara N Maxwell
Journal:  Breast Cancer Res Treat       Date:  2020-04-03       Impact factor: 4.872

8.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 9.  Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.

Authors:  Christian P Kratz; Maria Isabel Achatz; Laurence Brugières; Thierry Frebourg; Judy E Garber; Mary-Louise C Greer; Jordan R Hansford; Katherine A Janeway; Wendy K Kohlmann; Rose McGee; Charles G Mullighan; Kenan Onel; Kristian W Pajtler; Stefan M Pfister; Sharon A Savage; Joshua D Schiffman; Katherine A Schneider; Louise C Strong; D Gareth R Evans; Jonathan D Wasserman; Anita Villani; David Malkin
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

10.  Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.

Authors:  Yi-Long Wu; Masahiro Tsuboi; Jie He; Thomas John; Christian Grohe; Margarita Majem; Jonathan W Goldman; Konstantin Laktionov; Sang-We Kim; Terufumi Kato; Huu-Vinh Vu; Shun Lu; Kye-Young Lee; Charuwan Akewanlop; Chong-Jen Yu; Filippo de Marinis; Laura Bonanno; Manuel Domine; Frances A Shepherd; Lingmin Zeng; Rachel Hodge; Ajlan Atasoy; Yuri Rukazenkov; Roy S Herbst
Journal:  N Engl J Med       Date:  2020-09-19       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.